Price T Rowe Associates Inc Treace Medical Concepts, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,056 shares of TMCI stock, worth $178,554. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,056
Previous 15,604
22.12%
Holding current value
$178,554
Previous $91,000
56.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TMCI
# of Institutions
138Shares Held
38.1MCall Options Held
52KPut Options Held
19.1K-
Armistice Capital, LLC New York, NY6.21MShares$58.2 Million0.65% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$38.1 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.94MShares$27.5 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$25.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.14MShares$20.1 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $519M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...